8月1日 - ** 远程医疗公司Hims & Hers Health HIMS.N股价盘前下跌6.5%至61.88美元
** 据《华盛顿邮报》报道，特朗普政府计划将减肥药纳入医疗保险和医疗补助范围 (link)
** 报道称，拟议的计划将允许州医疗补助计划和医疗保险D部分保险计划自愿涵盖GLP-1药物，如诺和诺德的NOVOb.CO Ozempic和Wegovy，以及礼来的Mounjaro和Zepbound，用于体重管理
** 华盛顿邮报》援引文件报道称，拟议计划预计将于 2026 年 4 月开始实施医疗补助计划，2027 年 1 月开始实施医疗保险计划
** 截至上次收盘，股价年累计上涨 173
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.